Loading…
Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells
The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of pol...
Saved in:
Published in: | Doklady. Biological sciences 2016, Vol.466 (1), p.45-47 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183 |
---|---|
cites | cdi_FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183 |
container_end_page | 47 |
container_issue | 1 |
container_start_page | 45 |
container_title | Doklady. Biological sciences |
container_volume | 466 |
creator | Kunts, T. A. Karpukhina, K. V. Mikhaylova, E. S. Marinkin, I. O. Varaksin, N. A. Autenshlyus, A. I. Lyakhovich, V. V. |
description | The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma. |
doi_str_mv | 10.1134/S0012496616010026 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785243358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1785243358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183</originalsourceid><addsrcrecordid>eNqNkUtLxDAUhYMoOj5-gBsJuHFTvUnaJF2KjA8QXKjrkqbJ0LGTjEkrzL83dUYRRXCVm3u-e3LJQeiYwDkhLL94BCA0LzknHAgA5VtokkqZMQLFNpqMcjbqe2g_xjmkOwi2i_aoAEqYgAmaT601usfe4qXvVrrzTnVY6b59U70PEXuH9ar3L60zeBl8MyQp9eoVrjvvG6xN10WsXDO2FqprZ065HtfBqNhjrZw2YQ0doh2rumiONucBer6ePl3dZvcPN3dXl_eZZhR4JnKqbc6oKTg1nDHJSitrUzaKNjJvCPuoZSmItIZaYQVhVhFgAE2SJTtAZ2vftO7rYGJfLdo4bqCc8UOsiJAFzRkr_oMKAaIo5Yie_kDnfgjpsz4oTktekDxRZE3p4GMMxlbL0C5UWFUEqjGz6ldmaeZk4zzUC9N8TXyGlAC6BmKS3MyEb0__6foOqLSfWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776296514</pqid></control><display><type>article</type><title>Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells</title><source>Springer Link</source><creator>Kunts, T. A. ; Karpukhina, K. V. ; Mikhaylova, E. S. ; Marinkin, I. O. ; Varaksin, N. A. ; Autenshlyus, A. I. ; Lyakhovich, V. V.</creator><creatorcontrib>Kunts, T. A. ; Karpukhina, K. V. ; Mikhaylova, E. S. ; Marinkin, I. O. ; Varaksin, N. A. ; Autenshlyus, A. I. ; Lyakhovich, V. V.</creatorcontrib><description>The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.</description><identifier>ISSN: 0012-4966</identifier><identifier>EISSN: 1608-3105</identifier><identifier>DOI: 10.1134/S0012496616010026</identifier><identifier>PMID: 27021370</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Biomedical and Life Sciences ; Blood Cells - metabolism ; Blood Cells - pathology ; Carcinogenesis - genetics ; Carcinoma, Ductal, Breast - blood ; Carcinoma, Ductal, Breast - genetics ; Carcinoma, Ductal, Breast - pathology ; Cell Biology ; Concanavalin A - pharmacology ; Enzyme-Linked Immunosorbent Assay ; Evolutionary Biology ; Female ; Granulocyte Colony-Stimulating Factor - blood ; Granulocyte Colony-Stimulating Factor - genetics ; Humans ; Interleukin-18 - blood ; Interleukin-18 - genetics ; Interleukin-6 - blood ; Interleukin-6 - genetics ; Life Sciences ; Lipopolysaccharides - pharmacology ; Mitosis - genetics ; Neoplasm Invasiveness - genetics ; Neoplasm Metastasis ; Neovascularization, Pathologic - genetics ; Neovascularization, Pathologic - pathology ; Phytohemagglutinins - pharmacology ; Plant Sciences</subject><ispartof>Doklady. Biological sciences, 2016, Vol.466 (1), p.45-47</ispartof><rights>Pleiades Publishing, Ltd. 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183</citedby><cites>FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27021370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kunts, T. A.</creatorcontrib><creatorcontrib>Karpukhina, K. V.</creatorcontrib><creatorcontrib>Mikhaylova, E. S.</creatorcontrib><creatorcontrib>Marinkin, I. O.</creatorcontrib><creatorcontrib>Varaksin, N. A.</creatorcontrib><creatorcontrib>Autenshlyus, A. I.</creatorcontrib><creatorcontrib>Lyakhovich, V. V.</creatorcontrib><title>Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells</title><title>Doklady. Biological sciences</title><addtitle>Dokl Biol Sci</addtitle><addtitle>Dokl Biol Sci</addtitle><description>The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.</description><subject>Biomedical and Life Sciences</subject><subject>Blood Cells - metabolism</subject><subject>Blood Cells - pathology</subject><subject>Carcinogenesis - genetics</subject><subject>Carcinoma, Ductal, Breast - blood</subject><subject>Carcinoma, Ductal, Breast - genetics</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>Cell Biology</subject><subject>Concanavalin A - pharmacology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Evolutionary Biology</subject><subject>Female</subject><subject>Granulocyte Colony-Stimulating Factor - blood</subject><subject>Granulocyte Colony-Stimulating Factor - genetics</subject><subject>Humans</subject><subject>Interleukin-18 - blood</subject><subject>Interleukin-18 - genetics</subject><subject>Interleukin-6 - blood</subject><subject>Interleukin-6 - genetics</subject><subject>Life Sciences</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Mitosis - genetics</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neoplasm Metastasis</subject><subject>Neovascularization, Pathologic - genetics</subject><subject>Neovascularization, Pathologic - pathology</subject><subject>Phytohemagglutinins - pharmacology</subject><subject>Plant Sciences</subject><issn>0012-4966</issn><issn>1608-3105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkUtLxDAUhYMoOj5-gBsJuHFTvUnaJF2KjA8QXKjrkqbJ0LGTjEkrzL83dUYRRXCVm3u-e3LJQeiYwDkhLL94BCA0LzknHAgA5VtokkqZMQLFNpqMcjbqe2g_xjmkOwi2i_aoAEqYgAmaT601usfe4qXvVrrzTnVY6b59U70PEXuH9ar3L60zeBl8MyQp9eoVrjvvG6xN10WsXDO2FqprZ065HtfBqNhjrZw2YQ0doh2rumiONucBer6ePl3dZvcPN3dXl_eZZhR4JnKqbc6oKTg1nDHJSitrUzaKNjJvCPuoZSmItIZaYQVhVhFgAE2SJTtAZ2vftO7rYGJfLdo4bqCc8UOsiJAFzRkr_oMKAaIo5Yie_kDnfgjpsz4oTktekDxRZE3p4GMMxlbL0C5UWFUEqjGz6ldmaeZk4zzUC9N8TXyGlAC6BmKS3MyEb0__6foOqLSfWw</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Kunts, T. A.</creator><creator>Karpukhina, K. V.</creator><creator>Mikhaylova, E. S.</creator><creator>Marinkin, I. O.</creator><creator>Varaksin, N. A.</creator><creator>Autenshlyus, A. I.</creator><creator>Lyakhovich, V. V.</creator><general>Pleiades Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>2016</creationdate><title>Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells</title><author>Kunts, T. A. ; Karpukhina, K. V. ; Mikhaylova, E. S. ; Marinkin, I. O. ; Varaksin, N. A. ; Autenshlyus, A. I. ; Lyakhovich, V. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biomedical and Life Sciences</topic><topic>Blood Cells - metabolism</topic><topic>Blood Cells - pathology</topic><topic>Carcinogenesis - genetics</topic><topic>Carcinoma, Ductal, Breast - blood</topic><topic>Carcinoma, Ductal, Breast - genetics</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>Cell Biology</topic><topic>Concanavalin A - pharmacology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Evolutionary Biology</topic><topic>Female</topic><topic>Granulocyte Colony-Stimulating Factor - blood</topic><topic>Granulocyte Colony-Stimulating Factor - genetics</topic><topic>Humans</topic><topic>Interleukin-18 - blood</topic><topic>Interleukin-18 - genetics</topic><topic>Interleukin-6 - blood</topic><topic>Interleukin-6 - genetics</topic><topic>Life Sciences</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Mitosis - genetics</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neoplasm Metastasis</topic><topic>Neovascularization, Pathologic - genetics</topic><topic>Neovascularization, Pathologic - pathology</topic><topic>Phytohemagglutinins - pharmacology</topic><topic>Plant Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kunts, T. A.</creatorcontrib><creatorcontrib>Karpukhina, K. V.</creatorcontrib><creatorcontrib>Mikhaylova, E. S.</creatorcontrib><creatorcontrib>Marinkin, I. O.</creatorcontrib><creatorcontrib>Varaksin, N. A.</creatorcontrib><creatorcontrib>Autenshlyus, A. I.</creatorcontrib><creatorcontrib>Lyakhovich, V. V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Doklady. Biological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kunts, T. A.</au><au>Karpukhina, K. V.</au><au>Mikhaylova, E. S.</au><au>Marinkin, I. O.</au><au>Varaksin, N. A.</au><au>Autenshlyus, A. I.</au><au>Lyakhovich, V. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells</atitle><jtitle>Doklady. Biological sciences</jtitle><stitle>Dokl Biol Sci</stitle><addtitle>Dokl Biol Sci</addtitle><date>2016</date><risdate>2016</risdate><volume>466</volume><issue>1</issue><spage>45</spage><epage>47</epage><pages>45-47</pages><issn>0012-4966</issn><eissn>1608-3105</eissn><abstract>The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><pmid>27021370</pmid><doi>10.1134/S0012496616010026</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-4966 |
ispartof | Doklady. Biological sciences, 2016, Vol.466 (1), p.45-47 |
issn | 0012-4966 1608-3105 |
language | eng |
recordid | cdi_proquest_miscellaneous_1785243358 |
source | Springer Link |
subjects | Biomedical and Life Sciences Blood Cells - metabolism Blood Cells - pathology Carcinogenesis - genetics Carcinoma, Ductal, Breast - blood Carcinoma, Ductal, Breast - genetics Carcinoma, Ductal, Breast - pathology Cell Biology Concanavalin A - pharmacology Enzyme-Linked Immunosorbent Assay Evolutionary Biology Female Granulocyte Colony-Stimulating Factor - blood Granulocyte Colony-Stimulating Factor - genetics Humans Interleukin-18 - blood Interleukin-18 - genetics Interleukin-6 - blood Interleukin-6 - genetics Life Sciences Lipopolysaccharides - pharmacology Mitosis - genetics Neoplasm Invasiveness - genetics Neoplasm Metastasis Neovascularization, Pathologic - genetics Neovascularization, Pathologic - pathology Phytohemagglutinins - pharmacology Plant Sciences |
title | Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A33%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20polyclonal%20activators%20on%20cytokine%20production%20by%20blood%20cells%20and%20by%20malignant%20breast%20cancer%20cells&rft.jtitle=Doklady.%20Biological%20sciences&rft.au=Kunts,%20T.%20A.&rft.date=2016&rft.volume=466&rft.issue=1&rft.spage=45&rft.epage=47&rft.pages=45-47&rft.issn=0012-4966&rft.eissn=1608-3105&rft_id=info:doi/10.1134/S0012496616010026&rft_dat=%3Cproquest_cross%3E1785243358%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3206-742cf432e562e633839f8be9da2d84d13be9da89718fe2f7f713fa10300d4d183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1776296514&rft_id=info:pmid/27021370&rfr_iscdi=true |